Welcome to a collaborative work between Biological Mimetics, Inc. (BMI) and North Dakota State University (NDSU) aimed at developing an improved porcine circovirus-2 (PCV2) vaccine.
Through a decade long collaboration, BMI and NDSU scientists have applied the Immune Refocusing Technology to design an improved novel PCV2 vaccine to stimulate better cross-protective immunity.
This work addresses an important need in the U.S. Pork Industry: to protect animals from evolving and newly emerging strains of virus.
BMI seeks a manufacturing partner to bring this novel PCV2 vaccine to market.
The U.S. Pork Industry is of Key Importance for the U.S.:
- Represents 550,000 jobs
- Produces 23.2 billion pounds of pork
- 110 millions of hogs
- Is a $23.4 billion market*
- Infectious diseases cause significant economic losses
- PCV2 infections cause a number of diseases that reduce weight gain and decrease health status.
* https://nppc.org/pork-facts/